COMMUNIQUÉS West-GlobeNewswire

Idorsia announces half year results for 2017 - successful start of new biopharmaceutical company
03/08/2017
Financial Statements Half Year 2017 Press release PDF Financial Fact Sheet This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this [...]
Apricus Biosciences Provides Corporate Update and Second Quarter 2017 Financial Results
02/08/2017
Vitaros Drug-Device Human Factor Studies Successfully Completed Vitaros U.S. NDA Final Draft Completed with Re-Submission Expected in Current Quarter Conference Call / Webcast Today, August 2, 2017 at 4:30 p.m. ET SAN [...]
Advance Notice: Reviewed Financial Statement's announcement for the period 30 June 2017
02/08/2017
EASTPHARMA LTD. London, 02 August 2017 - EastPharma (EAST LI) informs that it will be releasing its reviewed financial statements for the period 30 June 2017 and a review of its main subsidiary DEVA Holding's financial [...]
Oriola Corporation - Repurchase of own shares on 2 August 2017
02/08/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 2 August 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 2 August 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 6440 Average price/share, EUR 3,63 Total [...]
Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2017 and Provide Clinical Development Update
02/08/2017
LONDON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Medtronic Expands Heart Valve Portfolio with FDA Approval and CE Mark of the Avalus(TM) Surgical Aortic Valve
02/08/2017
Introduction of New Pericardial Aortic Heart Valve in the U.S. and Europe Reinforces Company's Commitment to Comprehensive Solutions to Heart Valve Disease DUBLIN - August 2, 2017 - Medtronic plc (NYSE: MDT) today [...]
Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
02/08/2017
Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia Randomized, double-blind, placebo-controlled study to enroll up to 500 patients [...]
ProMIS Neurosciences Increases Size of Private Placement to $6 Million
02/08/2017
/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 2, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:ARFX.F; DB:23J) today [...]
Arix Bioscience participates in $67 million Series C financing for Amplyx Pharmaceuticals
02/08/2017
Arix Bioscience participates in $67 million Series C financing for Amplyx Pharmaceuticals Series C financing to fund Phase II clinical trials of APX001, a novel antifungal agent to treat life-threatening invasive [...]
Invivoscribe® lance le test de mutation LeukoStrat® CDx FLT3 sous forme de kit d'essai DVI labellisé CE
02/08/2017
SAN DIEGO, le 2 er août 2017 (GLOBE NEWSWIRE) - Invivoscribe ® Technologies Inc., une société internationale ayant de nombreuses années d'expérience en matière de solutions de test de clonalité et de biomarqueurs dans [...]
Eckert & Ziegler BEBIG : First Half-Year Results 2017 Published
02/08/2017
Seneffe - Belgium, August 2, 2017, Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) has announced today its half-year results 2017. The report including a selection of consolidated key [...]
Eckert & Ziegler BEBIG : Publication du résultat du premier semestre 2017
02/08/2017
Seneffe - Belgique, 2 août 2017, Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) a communiqué aujourd'hui son rapport du 1er semestre 2017. Le rapport qui comprend une sélection de [...]
DBV Technologies annonce le lancement d'EPITOPE, étude clinique de phase III d'évaluation de Viaskin Peanut dans le traitement des enfants de 1 à 3 ans atteints d'allergie à l'arachide
02/08/2017
Communiqué de presse Montrouge, France, le 2 août 2017 (7H30 CEST) DBV Technologies annonce le lancement d'EPITOPE, étude clinique de phase III d'évaluation de Viaskin Peanut dans le traitement des enfants de 1 à 3 ans [...]
DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age
02/08/2017
Press Release Montrouge, France,August 2, 2017 DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age Expansion of clinical program into younger children [...]
MDxHealth to Participate in Canaccord Genuity Growth Conference
02/08/2017
COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 2, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it will participate in the 37th [...]
MDxHealth participera à la Conférence Canaccord Genuity Growth
02/08/2017
ANNONCE D'ENTERPRISE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, le 2 août, 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui sa participation à la [...]
Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States
01/08/2017
Company announcement - No. 29/2017 Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States Zealand Pharma A/S has today commenced an initial public offering of American [...]
Prothena to Report Second Quarter 2017 Financial Results on August 8
01/08/2017
DUBLIN, Ireland, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]
Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017
01/08/2017
GAITHERSBURG, Md., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter financial and operating results following the close of U.S. financial markets on Tuesday [...]

Pages